Immunohistochemical expression of prostate tumour overexpressed 1 (PTOV1) in atypical adenomatous hyperplasia (AAH) of the prostate: Additional evidence linking AAH to adenocarcinoma

Cellular Oncology

Volumn 36, Issue 1, 2013, Pages 37-42

  Mazzucchelli, Roberta ^a   Scarpelli, Marina ^a   Barbisan, Francesca ^a   Santinelli, Alfredo ^a   Lopez Beltran, Antonio ^b   Cheng, Liang ^c   Montironi, Rodolfo ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b Universidad de Cordoba   (Spain)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosis; Atypical adenomatous hyperplasia; Cell proliferation; High grade prostatic intraepithelial neoplasia; Ki67; Prostate cancer; Prostate tumour overexpressed 1; PTOV1

Indexed keywords

KI 67 ANTIGEN; PROSTATE TUMOR OVEREXPRESSED 1 PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIUM; GENE OVEREXPRESSION; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE ADENOMA; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION;

ADENOCARCINOMA; AGED; DISEASE PROGRESSION; EPITHELIUM; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM PROTEINS; PROSTATE; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 84877064012     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-012-0111-7     Document Type: Article

References (25)

1. D.G. Bostwick, F. Algaba, M.B. Amin, A. Ayala, J. Eble, N. Goldstein, B. Helpap, P. Humphrey, D. Grignon, E.C. Jones, Consensus statement on terminology: recommendation to use atypical adenomatous hyperplasia in place of adenosis of the prostate. Am J Surg Pathol 18, 1069-1070 (1994)
2. D.G. Bostwick, L. Cheng, Overdiagnosis of prostatic adenocarcinoma. Semin Urol Oncol 17, 199-205 (1999)
3. D.G. Bostwick, J. Qian, Atypical adenomatous hyperplasia of the prostate. Relationship with carcinoma in 217 whole-mount radical prostatectomies. Am J Surg Pathol 19, 506-518 (1995)
4. D.G. Bostwick, J. Srigley, D. Grignon, J. Maksem, P. Humphrey, T.H. van der Kwast, D. Bose, J. Harrison, R.H. Young, Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma. Hum Pathol 24, 819-832 (1993)
5. J.I. Epstein, Adenosis (atypical adenomatous hyperplasia): histopathology and relationship to carcinoma. Pathol Res Pract 191, 888-898 (1995)
6. P.B. Gaudin, J.I. Epstein, Adenosis of the prostate. Histologic features in transurethral resection specimens. Am J Surg Pathol 18, 863-870 (1994)
7. A. Lopez-Beltran, J. Qian, R. Montironi, R.J. Luque, D.G. Bostwick, Atypical adenomatous hyperplasia (adenosis) of the prostate: DNA ploidy analysis and immunophenotype. Int J Surg Pathol 13, 167-173 (2005)
8. R. Montironi, P.H. Bartels, P.W. Hamilton, D. Thompson, Atypical adenomatous hyperplasia (adenosis) of the prostate: development of a Bayesian belief network for its distinction from well-differentiated adenocarcinoma. Hum Pathol 27, 396-407 (1996)
9. L. Cheng, A. Shan, J.C. Cheville, J. Qian, D.G. Bostwick, Atypical adenomatous hyperplasia of the prostate: a premalignant lesion? Cancer Res 58, 389-391 (1998)
10. J.A. Doll, X. Zhu, J. Furman, Z. Kaleem, C. Torres, P.A. Humphrey, H. Donis-Keller, Genetic analysis of prostatic atypical adenomatous hyperplasia (adenosis). Am J Pathol 155, 967-971 (1999)
11. C. Zhang, R. Montironi, G.T. MacLennan, A. Lopez-Beltran, Y. Li, P.H. Tan, M. Wang, S. Zhang, K.A. Iczkowski, L. Cheng, Is atypical adenomatous hyperplasia of the prostate a precursor lesion? Prostate 71, 1746-1751 (2011)
12. P. Benedit, R. Paciucci, T.M. Thomson, M. Valeri, M. Nadal, C. Càceres, I. de Torres, X. Estivill, J.J. Lozano, J. Morote, J. Reventós, PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks. Oncogene 20, 1455-1464 (2001)
13. S. Fernandez, J.L. Mosquera, L. Alaña, A. Sanchez-Pla, J. Morote, S. Ramón, Y. Cajal, J. Reventós, I. de Torres, R. Paciucci, PTOV1 is overexpressed in human high grade malignant tumors. Virchows Arch 458, 323-330 (2011)
14. J. Xu, J.A. Stolk, X. Zhang, S.J. Silva, R.L. Houghton, M. Matsumura, T.S. Vedvick, K.B. Leslie, R. Badaro, S.G. Reed, Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res 60, 1677-1682 (2000)
15. A. Santinelli, R. Mazzucchelli, F. Barbisan, A. Lopez-Beltran, L. Cheng, M. Scarpelli, R. Montironi, alpha-Methylacyl coenzyme A racemase, Ki-67, and topoisomerase IIalpha in cystoprostatectomies with incidental prostate cancer. Am J Clin Pathol 128(657-666) (2007)
16. R. Mazzucchelli, F. Barbisan, A. Santinelli, A. Lopez-Beltran, L. Cheng, M. Scarpelli, R. Montironi, Immunohistochemical expression of prostate tumor overexpressed 1 in cystoprostatectomies with incidental and insignificant prostate cancer Further evidence for field effect in prostatic carcinogenesis. Hum Pathol 42, 1931-1936 (2011)
17. J.R. Srigley, Benign mimickers of prostatic adenocarcinoma. Mod Pathol 17, 328-348 (2004)
18. P.N. Brawn, Adenosis of the prostate: a dysplastic lesion that can be confused with prostate adenocarcinoma. Cancer 49, 826-833 (1982)
19. B. Helpap, Cell kinetic studies on prostatic intraepithelial neoplasia (PIN) and atypical adenomatous hyperplasia (AAH) of the prostate. Pathol Res Pract 191, 904-907 (1995)
20. N.S. Goldstein, J. Qian, D.G. Bostwick, Mucin expression in atypical adenomatous hyperplasia of the prostate. Hum Pathol 26, 887-891 (1995)
21. J. Morote, S. Fernández, L. Alaña, C. Iglesias, J. Planas, J. Reventós, S. Ramón Y Cajal, R. Paciucci, I.M. de Torres, PTOV1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy. Clin Cancer Res 14, 2617-2622 (2008)
22. A. Santamaría, P.L. Fernández, X. Farré, P. Benedit, J. Reventós, J. Morote, R. Paciucci, T.M. Thomson, PTOV-1, a novel protein overexpressed in prostate cancer, shuttles between the cytoplasm and the nucleus and promotes entry into the S phase of the cell division cycle. Am J Pathol 162, 897-905 (2003)
23. A. Santamaría, E. Castellanos, V. Gómez, P. Benedit, J. Renau-Piqueras, J. Morote, J. Reventós, T.M. Thomson, R. Paciucci, PTOV1 enables the nuclear translocation and mitogenic activity of flotillin-1, a major protein of lipid rafts. Mol Cell Biol 25, 1900-1911 (2005)
24. M. Scarpelli, R. Mazzucchelli, F. Barbisan, A. Santinelli, A. Lopez-Beltran, L. Cheng, R. Montironi, Is there a role for prostate tumour overexpressed-1 in the diagnosis of HGPIN and of prostatic adenocarcinoma? A comparison with alpha-methylacyl CoA racemase. Int J Immunopathol Pharmacol 25, 67-74 (2012)
25. X.J. Yang, C.L. Wu, B.A. Woda, K. Dresser, M. Tretiakova, G.R. Fanger, Z. Jiang, Expression of alpha-Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol 26, 921-925 (2002)